[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL3715356T3 - Sposób oczyszczania polipeptydów - Google Patents

Sposób oczyszczania polipeptydów

Info

Publication number
PL3715356T3
PL3715356T3 PL20162007.7T PL20162007T PL3715356T3 PL 3715356 T3 PL3715356 T3 PL 3715356T3 PL 20162007 T PL20162007 T PL 20162007T PL 3715356 T3 PL3715356 T3 PL 3715356T3
Authority
PL
Poland
Prior art keywords
purifying polypeptides
polypeptides
purifying
Prior art date
Application number
PL20162007.7T
Other languages
English (en)
Inventor
Adam Charlton
Mark Napoli
Paul Smrdelj
Anthony Stowers
Vicky Pirzas
Magnus Schroeder
Ian Walker
Original Assignee
Csl Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42229094&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3715356(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csl Limited filed Critical Csl Limited
Publication of PL3715356T3 publication Critical patent/PL3715356T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/644—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21022—Coagulation factor IXa (3.4.21.22)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
PL20162007.7T 2009-12-18 2010-12-15 Sposób oczyszczania polipeptydów PL3715356T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09015707 2009-12-18

Publications (1)

Publication Number Publication Date
PL3715356T3 true PL3715356T3 (pl) 2024-03-11

Family

ID=42229094

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20162007.7T PL3715356T3 (pl) 2009-12-18 2010-12-15 Sposób oczyszczania polipeptydów

Country Status (12)

Country Link
US (3) US20140080200A1 (pl)
EP (3) EP3715356B1 (pl)
JP (1) JP5984676B2 (pl)
KR (1) KR20120108989A (pl)
CN (2) CN102666568B (pl)
AU (1) AU2010332959B2 (pl)
CA (1) CA2783207A1 (pl)
DK (1) DK2513135T3 (pl)
ES (2) ES2968448T3 (pl)
PL (1) PL3715356T3 (pl)
SG (2) SG181496A1 (pl)
WO (1) WO2011073235A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG181496A1 (en) 2009-12-18 2012-07-30 Csl Ltd Method of purifying polypeptides
KR101780518B1 (ko) * 2010-04-29 2017-09-21 박스알타 인코퍼레이티드 음이온 교환 수지상에서의 2가 양이온 결합 단백질의 정제 방법
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
JP6117219B2 (ja) 2011-10-14 2017-04-19 バクスアルタ ゲーエムベーハー 陰イオン交換クロマトグラフィによるタンパク質の精製方法
JP6236008B2 (ja) 2011-10-14 2017-11-22 バクスアルタ ゲーエムベーハー アニオン交換クロマトグラフィーによるタンパク質の精製
WO2013158279A1 (en) * 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
SG11201504249XA (en) 2012-09-02 2015-07-30 Abbvie Inc Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
US10023608B1 (en) 2013-03-13 2018-07-17 Amgen Inc. Protein purification methods to remove impurities
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US10202417B2 (en) 2013-03-15 2019-02-12 Baxalta Incorporated Purification method for vitamin K dependent proteins by anion exchange chromatography
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
WO2017127567A1 (en) * 2016-01-19 2017-07-27 Genebiologics, Llc Production of arginine-rich proteins and use as a fertilizer and germination enhancer
MX2020009788A (es) * 2018-03-21 2020-12-09 Takeda Pharmaceuticals Co Separación de factor de von willebrand (vwf) y propéptido de factor de von willebrand (vwf) por métodos cromatográficos.
CN114787622A (zh) * 2019-12-05 2022-07-22 沃特世科技公司 用于提高回收率并将系统损失减到最小的聚膦酸

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US499437A (en) 1893-06-13 Ditching-scoop
EP0316558A1 (en) 1982-08-04 1989-05-24 Btg International Limited Factor IX DNA
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
JPS63501471A (ja) 1984-12-27 1988-06-09 サントリー株式会社 インタ−フェロンの精製方法
GR860984B (en) 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4994371A (en) 1987-08-28 1991-02-19 Davie Earl W DNA preparation of Christmas factor and use of DNA sequences
US5061815A (en) * 1988-07-06 1991-10-29 Zinpro Corporation Metal lysine complexes and method for producing metal lysine complexes
US5136026A (en) 1989-04-10 1992-08-04 Behringwerke Aktiengesellschaft Process for removing toxins from protein solutions
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5278144A (en) 1990-09-04 1994-01-11 Cor Therapeutics, Inc. Antithrombosis agents
US5288612A (en) 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
US5567602A (en) 1992-08-12 1996-10-22 Arris Pharmaceutical Corporation Recombinant production of chymase
US5641887A (en) * 1994-04-01 1997-06-24 University Of Pittsburgh Extraction of metals in carbon dioxide and chelating agents therefor
US5589571A (en) 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors
WO1996035786A1 (fr) * 1995-05-09 1996-11-14 Fujikawa, Yoshio Proteine de perle (nacreine) et son procede de production
US6268487B1 (en) * 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
CA2268747A1 (en) 1996-11-15 1998-05-22 Genentech, Inc. Purification of neurotrophins
AT409334B (de) 1997-09-19 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
US20030036629A1 (en) 1997-12-12 2003-02-20 Barry Foster Novel tgf-beta protein purification methods
AU3273200A (en) * 1999-03-15 2000-10-04 Novo Nordisk A/S Ion exchange chromatographic separation of glp-1 and related peptides
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
SE9904237D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab New compound
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
EP1450847B1 (en) 2001-11-13 2010-09-29 Genentech, Inc. APO2 ligand/ TRAIL formulations and uses thereof
US7741285B2 (en) 2001-11-13 2010-06-22 Genentech, Inc. APO-2 ligand/trail formulations
HUE025101T2 (en) 2002-04-26 2016-02-29 Genentech Inc Purification of proteins other than affinity purification
AU2003242507A1 (en) * 2002-07-12 2004-02-02 Novo Nordisk A/S A tissue factor binding immunoconjugate comprising factor viia
US20040048315A1 (en) * 2002-08-28 2004-03-11 Pharmacia Corporation Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
SI1428878T1 (sl) 2002-12-13 2009-02-28 Bioceuticals Arzneimittel Ag Postopek za proizvodnjo in čiščenje eritropoietina
CN101031644A (zh) * 2004-09-29 2007-09-05 诺和诺德医疗保健公司 通过分级洗脱从阴离子交换材料中纯化批量凝血因子ⅶ多肽
KR20130128013A (ko) 2004-12-23 2013-11-25 노보 노르디스크 헬스 케어 악티엔게젤샤프트 관심있는 비타민 ｋ-의존성 단백질을 포함한 조성물 중의 단백질 오염물질의 양의 감소
CN101218247A (zh) 2005-04-11 2008-07-09 米德列斯公司 利用hcic和离子交换层析的蛋白质纯化
BRPI0616600A2 (pt) * 2005-08-31 2011-06-28 Centocor Inc linhagens de célula hospedeira para produção de região constante de anticorpo com função efetora aumentada
EP1924688A1 (en) * 2005-09-01 2008-05-28 Novo Nordisk Health Care AG Purification of coagulation factor vii polypeptides
WO2007071768A1 (en) 2005-12-23 2007-06-28 Novo Nordisk A/S Purification of proteins using preparative reverse phase chromatography (rpc)
AU2007227700A1 (en) 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
NZ610566A (en) 2006-04-05 2014-09-26 Abbvie Biotechnology Ltd Antibody purification
DK3896090T3 (da) 2006-06-14 2022-03-21 Csl Behring Gmbh Proteolytisk spalteligt fusionsprotein omfattende en blodkoagutionsfaktor
JP5374840B2 (ja) * 2006-07-20 2013-12-25 Ｊｎｃ株式会社 カルシウム結合発光蛋白質、それをコードする遺伝子およびその用途
EP2059258B1 (en) 2006-09-08 2019-11-13 Wyeth LLC Arginine wash in protein purification using affinity chromatography
US8362217B2 (en) 2006-12-21 2013-01-29 Emd Millipore Corporation Purification of proteins
ES2374330T3 (es) 2007-01-22 2012-02-15 Genentech, Inc. Precipitación con polielectrolito y purificación de anticuerpos.
EP2125866B1 (en) * 2007-02-28 2013-05-22 Baxter International Inc. Method for the purification of recombinant blood coagulation factor ix enriched in sulfated and/or phosphorylated molecules
WO2008122089A1 (en) 2007-04-05 2008-10-16 The University Of Queensland Method of purifying recombinant peptides by selective precipitation
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物
CA2726823A1 (en) 2008-06-03 2009-12-10 Patrys Limited Process for purification of antibodies
MX2011005474A (es) * 2008-12-02 2011-06-16 Novo Nordisk Healthcare Ag Purificacion de polipeptido.
WO2011018515A1 (en) * 2009-08-14 2011-02-17 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
SG181496A1 (en) 2009-12-18 2012-07-30 Csl Ltd Method of purifying polypeptides

Also Published As

Publication number Publication date
AU2010332959B2 (en) 2015-08-06
CA2783207A1 (en) 2011-06-23
US20190330267A1 (en) 2019-10-31
EP2513135A1 (en) 2012-10-24
SG181496A1 (en) 2012-07-30
CN102666568A (zh) 2012-09-12
WO2011073235A1 (en) 2011-06-23
EP3715356A1 (en) 2020-09-30
DK2513135T3 (da) 2020-05-18
EP3715356C0 (en) 2023-10-11
EP4328305A2 (en) 2024-02-28
EP4328305A3 (en) 2024-08-14
SG10201407983VA (en) 2015-01-29
US20160185816A1 (en) 2016-06-30
EP2513135B1 (en) 2020-04-22
AU2010332959A1 (en) 2012-07-05
KR20120108989A (ko) 2012-10-05
EP3715356B1 (en) 2023-10-11
CN104193798A (zh) 2014-12-10
US20140080200A1 (en) 2014-03-20
ES2968448T3 (es) 2024-05-09
JP5984676B2 (ja) 2016-09-06
ES2796829T3 (es) 2020-11-30
JP2013514310A (ja) 2013-04-25
CN102666568B (zh) 2015-12-09

Similar Documents

Publication Publication Date Title
IL261147A (en) Methods for purification of polypeptides
EP3715356C0 (en) METHOD FOR PURIFYING POLYPEPTIDES
IL225650A0 (en) Protein purification processes
EP2411122A4 (en) METHOD FOR SEPARATING GASES
PL2522724T3 (pl) Sposób modyfikowania polipetydów do oczyszczania multimerów polipeptydowych
ZA201202274B (en) Gas purification configurations and method
EP2613857A4 (en) PROCESS FOR PURIFYING IMMUNOCONJUGATES OR ACTIVE POLYPEPTIDES
IL243248A0 (en) Purification method
EP2395211A4 (en) EXHAUST PURIFICATION APPARATUS
GB0922623D0 (en) Methods for the purification of cucurbituril
ME02162B (me) Proces prečišćavanja proteina
IL206158A0 (en) Purification of not-glycosylated polypeptides
EP2519537A4 (en) CLEANING PROTEINS
ZA201302330B (en) Method for purifying water
PT2427482T (pt) Método para purificação de polipéptidos alvo
ZA201200420B (en) Method for the purification of protein complexes
GB2459738B (en) Method of purification
EP2404891A4 (en) PROCESS FOR THE PREPARATION OF ACYLBENZENES
GB0903026D0 (en) Novel method
EP2454202A4 (en) PROCESS FOR BIOLOGICAL CLEANING
GB2470361B (en) Method of casting
GB0912071D0 (en) Method of analysis
TWM372210U (en) Structure of filtration bottle
GB0922292D0 (en) Novel Method